List of Tables
Table 1. Global Peptide Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide Therapeutics Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Peptide Therapeutics Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Peptide Therapeutics Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Peptide Therapeutics Drugs Market Share by Region (2018-2023)
Table 9. Global Peptide Therapeutics Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Peptide Therapeutics Drugs Market Share by Region (2024-2029)
Table 11. Peptide Therapeutics Drugs Market Trends
Table 12. Peptide Therapeutics Drugs Market Drivers
Table 13. Peptide Therapeutics Drugs Market Challenges
Table 14. Peptide Therapeutics Drugs Market Restraints
Table 15. Global Peptide Therapeutics Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Peptide Therapeutics Drugs Market Share by Players (2018-2023)
Table 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2022)
Table 18. Ranking of Global Top Peptide Therapeutics Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Therapeutics Drugs Product Solution and Service
Table 22. Date of Enter into Peptide Therapeutics Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Therapeutics Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Peptide Therapeutics Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2024-2029)
Table 32. North America Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Peptide Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Peptide Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Peptide Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Peptide Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Peptide Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Peptide Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Peptide Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Sanofi Company Detail
Table 48. Sanofi Business Overview
Table 49. Sanofi Peptide Therapeutics Drugs Product
Table 50. Sanofi Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 51. Sanofi Recent Development
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Peptide Therapeutics Drugs Product
Table 55. Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. Novo Nordisk Company Detail
Table 58. Novo Nordisk Business Overview
Table 59. Novo Nordisk Peptide Therapeutics Drugs Product
Table 60. Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 61. Novo Nordisk Recent Development
Table 62. Takeda Company Detail
Table 63. Takeda Business Overview
Table 64. Takeda Peptide Therapeutics Drugs Product
Table 65. Takeda Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Teva Company Detail
Table 68. Teva Business Overview
Table 69. Teva Peptide Therapeutics Drugs Product
Table 70. Teva Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 71. Teva Recent Development
Table 72. Novartis Company Detail
Table 73. Novartis Business Overview
Table 74. Novartis Peptide Therapeutics Drugs Product
Table 75. Novartis Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. AstraZeneca Company Detail
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Peptide Therapeutics Drugs Product
Table 80. AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Ipsen Company Detail
Table 83. Ipsen Business Overview
Table 84. Ipsen Peptide Therapeutics Drugs Product
Table 85. Ipsen Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 86. Ipsen Recent Development
Table 87. AbbVie Company Detail
Table 88. AbbVie Business Overview
Table 89. AbbVie Peptide Therapeutics Drugs Product
Table 90. AbbVie Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 91. AbbVie Recent Development
Table 92. Allergan Company Detail
Table 93. Allergan Business Overview
Table 94. Allergan Peptide Therapeutics Drugs Product
Table 95. Allergan Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 96. Allergan Recent Development
Table 97. Ferring Company Detail
Table 98. Ferring Business Overview
Table 99. Ferring Peptide Therapeutics Drugs Product
Table 100. Ferring Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 101. Ferring Recent Development
Table 102. Merck Company Detail
Table 103. Merck Business Overview
Table 104. Merck Peptide Therapeutics Drugs Product
Table 105. Merck Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 106. Merck Recent Development
Table 107. JNJ Company Detail
Table 108. JNJ Business Overview
Table 109. JNJ Peptide Therapeutics Drugs Product
Table 110. JNJ Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 111. JNJ Recent Development
Table 112. Tarix Pharmaceuticals Company Detail
Table 113. Tarix Pharmaceuticals Business Overview
Table 114. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product
Table 115. Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 116. Tarix Pharmaceuticals Recent Development
Table 117. Lonza Company Detail
Table 118. Lonza Business Overview
Table 119. Lonza Peptide Therapeutics Drugs Product
Table 120. Lonza Revenue in Peptide Therapeutics Drugs Business (2018-2023) & (US$ Million)
Table 121. Lonza Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Therapeutics Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Peptide Therapeutics Drugs Market Share by Type: 2022 VS 2029
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Other Features
Figure 6. Global Peptide Therapeutics Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Peptide Therapeutics Drugs Market Share by Application: 2022 VS 2029
Figure 8. Cancer Case Studies
Figure 9. Metabolic Disorders Case Studies
Figure 10. Central Nervous System Case Studies
Figure 11. Other Case Studies
Figure 12. Peptide Therapeutics Drugs Report Years Considered
Figure 13. Global Peptide Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Peptide Therapeutics Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Peptide Therapeutics Drugs Market Share by Region: 2022 VS 2029
Figure 16. Global Peptide Therapeutics Drugs Market Share by Players in 2022
Figure 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2022
Figure 19. North America Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Peptide Therapeutics Drugs Market Share by Country (2018-2029)
Figure 21. United States Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Peptide Therapeutics Drugs Market Share by Country (2018-2029)
Figure 25. Germany Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Peptide Therapeutics Drugs Market Share by Region (2018-2029)
Figure 33. China Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Peptide Therapeutics Drugs Market Share by Country (2018-2029)
Figure 41. Mexico Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2018-2029)
Figure 45. Turkey Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Peptide Therapeutics Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Sanofi Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 48. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 49. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 50. Takeda Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 51. Teva Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 53. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 54. Ipsen Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 56. Allergan Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 57. Ferring Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 58. Merck Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 59. JNJ Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 60. Tarix Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 61. Lonza Revenue Growth Rate in Peptide Therapeutics Drugs Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed